Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ghobrial

Showing results (381-390 of 532) with videos related to

Pageof 54
Sort By:
Cancer Research Communications|February 21, 2026
Diagnostic Outcomes Among Patients with Positive Multi-Cancer Early Detection Test ResultsElizabeth K O'Donnell, Tia L Kauffman, Sydney Asnis, et al.
American Journal of Hematology|July 24, 2010
Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström MacroglobulinemiaIrene M Ghobrial, Wanling Xie, Swaminathan Padmanabhan, et al.
Endocrinology|October 5, 2017
Metformin Affects Cortical Bone Mass and Marrow Adiposity in Diet-Induced Obesity in Male MiceSheila Bornstein, Michele Moschetta, Yawara Kawano, et al.
Transplantation|February 25, 1999
A simple model to estimate survival after retransplantation of the liverJ F Markmann, J Gornbein, J S Markowitz, et al.
Annals of Surgery|August 23, 2002
Pretransplant model to predict posttransplant survival in liver transplant patientsRafik M Ghobrial, Jeffery Gornbein, Randy Steadman, et al.
Leukemia|October 25, 2016
The LIN28B/let-7 axis is a novel therapeutic pathway in multiple myelomaS Manier, J T Powers, A Sacco, et al.
Blood|May 27, 2014
Carfilzomib, rituximab, and dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenström's macroglobulinemiaSteven P Treon, Christina K Tripsas, Kirsten Meid, et al.
Nature Communications|November 17, 2022
Single cell characterization of myeloma and its precursor conditions reveals transcriptional signatures of early tumorigenesisRebecca Boiarsky, Nicholas J Haradhvala, Jean-Baptiste Alberge, et al.
Journal of Biomedical Optics|February 2, 2011
Optical techniques for tracking multiple myeloma engraftment, growth, and response to therapyJudith M Runnels, Alicia L Carlson, Costas Pitsillides, et al.
Blood|December 8, 2009
Dual targeting of the PI3K/Akt/mTOR pathway as an antitumor strategy in Waldenstrom macroglobulinemiaAldo M Roccaro, Antonio Sacco, Emanuel N Husu, et al.
Pageof 54

Showing results (381-390 of 532) with videos related to

Sort By:
Pageof 54
Cancer Research Communications|February 21, 2026
Diagnostic Outcomes Among Patients with Positive Multi-Cancer Early Detection Test ResultsElizabeth K O'Donnell, Tia L Kauffman, Sydney Asnis, et al.
American Journal of Hematology|July 24, 2010
Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström MacroglobulinemiaIrene M Ghobrial, Wanling Xie, Swaminathan Padmanabhan, et al.
Endocrinology|October 5, 2017
Metformin Affects Cortical Bone Mass and Marrow Adiposity in Diet-Induced Obesity in Male MiceSheila Bornstein, Michele Moschetta, Yawara Kawano, et al.
Transplantation|February 25, 1999
A simple model to estimate survival after retransplantation of the liverJ F Markmann, J Gornbein, J S Markowitz, et al.
Annals of Surgery|August 23, 2002
Pretransplant model to predict posttransplant survival in liver transplant patientsRafik M Ghobrial, Jeffery Gornbein, Randy Steadman, et al.
Leukemia|October 25, 2016
The LIN28B/let-7 axis is a novel therapeutic pathway in multiple myelomaS Manier, J T Powers, A Sacco, et al.
Blood|May 27, 2014
Carfilzomib, rituximab, and dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenström's macroglobulinemiaSteven P Treon, Christina K Tripsas, Kirsten Meid, et al.
Nature Communications|November 17, 2022
Single cell characterization of myeloma and its precursor conditions reveals transcriptional signatures of early tumorigenesisRebecca Boiarsky, Nicholas J Haradhvala, Jean-Baptiste Alberge, et al.
Journal of Biomedical Optics|February 2, 2011
Optical techniques for tracking multiple myeloma engraftment, growth, and response to therapyJudith M Runnels, Alicia L Carlson, Costas Pitsillides, et al.
Blood|December 8, 2009
Dual targeting of the PI3K/Akt/mTOR pathway as an antitumor strategy in Waldenstrom macroglobulinemiaAldo M Roccaro, Antonio Sacco, Emanuel N Husu, et al.
Pageof 54